Published in Am J Epidemiol on December 15, 1993
Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart (1997) 2.50
Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul Study. Biol Psychiatry (2007) 2.44
The relationship of retinol binding protein 4 to changes in insulin resistance and cardiometabolic risk in overweight black adolescents. J Pediatr (2008) 1.54
Occupational exposure to dust: inflammation and ischaemic heart disease. Occup Environ Med (1997) 1.39
Elevated fibrinogen levels and subsequent subclinical atherosclerosis: the CARDIA Study. Atherosclerosis (2008) 1.29
Socioeconomic status gradients in inflammation in adolescence. Psychosom Med (2013) 1.15
Smoking, fibrinogen and cancer mortality. J Natl Med Assoc (2007) 0.86
Level of fibrinogen and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe. J Epidemiol Community Health (2002) 0.86
Blood Pressure and Fibrinogen Responses to Mental Stress as Predictors of Incident Hypertension over an 8-Year Period. Ann Behav Med (2016) 0.85
Relationship between two alternative occupational stress models and arterial stiffness: a cross-sectional study among Japanese workers. Int Arch Occup Environ Health (2008) 0.85
Variables associated with fibrinogen in a population-based study: interaction between smoking and age on fibrinogen concentration. Eur J Epidemiol (2001) 0.82
Gender-specific risk factors for peripheral artery disease in a voluntary screening population. J Am Heart Assoc (2014) 0.82
Association between job characteristics and plasma fibrinogen in a normal working population: a cross sectional analysis in referents of the SHEEP Study. Stockholm Heart Epidemiology Program. J Epidemiol Community Health (1999) 0.82
Sex-based differences in the inflammatory profile of peripheral artery disease and the association with primary patency of lower extremity vein bypass grafts. J Vasc Surg (2012) 0.75
Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care (1997) 23.95
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med (1997) 18.85
CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol (1988) 15.40
Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation (1999) 8.04
Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem (1995) 7.73
The Sleep Heart Health Study: design, rationale, and methods. Sleep (1997) 7.55
Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation (2000) 7.37
Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med (1999) 6.92
Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation (1995) 6.55
Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. JAMA (1993) 6.27
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol (2000) 5.59
The Strong Heart Study. A study of cardiovascular disease in American Indians: design and methods. Am J Epidemiol (1990) 4.89
Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc (1999) 4.84
Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem (1997) 4.77
Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med (1997) 4.27
Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol (2000) 4.16
Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet (1999) 4.07
Recruitment in the Coronary Artery Disease Risk Development in Young Adults (Cardia) Study. Control Clin Trials (1987) 4.05
Delineating the genetic basis of systemic lupus erythematosus. Immunity (2001) 4.02
Abnormal glucose metabolism and pancreatic cancer mortality. JAMA (2000) 4.01
Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA (2001) 3.90
Benefit of a favorable cardiovascular risk-factor profile in middle age with respect to Medicare costs. N Engl J Med (1998) 3.89
Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. Am J Epidemiol (1996) 3.82
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Diabetes in older adults: comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification. Lancet (1998) 3.61
Impact of diabetes on cardiac structure and function: the strong heart study. Circulation (2000) 3.56
Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med (1988) 3.41
The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord (2001) 3.39
Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults. JAMA (1999) 3.34
Lower ankle/brachial index, as calculated by averaging the dorsalis pedis and posterior tibial arterial pressures, and association with leg functioning in peripheral arterial disease. J Vasc Surg (2000) 3.33
Cardiovascular risk factors in young adults. The CARDIA baseline monograph. Control Clin Trials (1991) 3.30
Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med (1988) 3.19
RAP1 and telomere structure regulate telomere position effects in Saccharomyces cerevisiae. Genes Dev (1993) 3.18
A study of the reliability and comparative validity of the cardia dietary history. Ethn Dis (1994) 3.05
The CARDIA dietary history: development, implementation, and evaluation. J Am Diet Assoc (1991) 3.04
Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science (1997) 2.92
Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation (1998) 2.83
Statistical methods to assess and minimize the role of intra-individual variability in obscuring the relationship between dietary lipids and serum cholesterol. J Chronic Dis (1978) 2.72
Dietary protein and weight reduction: a statement for healthcare professionals from the Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association. Circulation (2001) 2.71
Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol (2001) 2.68
Continuing Colorado plateau uplift by delamination-style convective lithospheric downwelling. Nature (2011) 2.68
Dual bidirectional promoters at the mouse dhfr locus: cloning and characterization of two mRNA classes of the divergently transcribed Rep-1 gene. Mol Cell Biol (1989) 2.66
Relationship of education to major risk factors and death from coronary heart disease, cardiovascular diseases and all causes, Findings of three Chicago epidemiologic studies. Circulation (1982) 2.65
Assessment of the association between habitual salt intake and high blood pressure: methodological problems. Am J Epidemiol (1979) 2.56
Cardiovascular disease risk factors among American Indians. The Strong Heart Study. Am J Epidemiol (1995) 2.53
AHA Science Advisory: Lyon Diet Heart Study. Benefits of a Mediterranean-style, National Cholesterol Education Program/American Heart Association Step I Dietary Pattern on Cardiovascular Disease. Circulation (2001) 2.51
The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes (2001) 2.47
PRAK, a novel protein kinase regulated by the p38 MAP kinase. EMBO J (1998) 2.44
All-cause mortality and cardiovascular disease mortality in three American Indian populations, aged 45-74 years, 1984-1988. The Strong Heart Study. Am J Epidemiol (1998) 2.43
The impact of weight change on cardiovascular disease risk factors in young black and white adults: the CARDIA study. Int J Obes Relat Metab Disord (2003) 2.43
Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis (2001) 2.40
Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst (1999) 2.40
Relationship of blood pressure to 25-year mortality due to coronary heart disease, cardiovascular diseases, and all causes in young adult men: the Chicago Heart Association Detection Project in Industry. Arch Intern Med (2001) 2.36
Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem (1999) 2.35
Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation (1999) 2.31
INTERMAP: background, aims, design, methods, and descriptive statistics (nondietary). J Hum Hypertens (2003) 2.27
Diabetes and impaired glucose tolerance in three American Indian populations aged 45-74 years. The Strong Heart Study. Diabetes Care (1995) 2.26
Overview of the MHC fine mapping data. Diabetes Obes Metab (2009) 2.24
Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum (1999) 2.21
Elucidating the essential role of the A14 phosphoprotein in vaccinia virus morphogenesis: construction and characterization of a tetracycline-inducible recombinant. J Virol (2000) 2.20
Inflammation in cardiovascular disease: cart, horse, or both? Circulation (1998) 2.18
Ten-year incidence of elevated blood pressure and its predictors: the CARDIA study. Coronary Artery Risk Development in (Young) Adults. J Hum Hypertens (1999) 2.17
Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol (1999) 2.15
Relations of left ventricular mass to fat-free and adipose body mass: the strong heart study. The Strong Heart Study Investigators. Circulation (1998) 2.14
State-independent experimental test of quantum contextuality in an indivisible system. Phys Rev Lett (2012) 2.13
Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians: The Strong Heart Study. Circulation (2000) 2.10
Effect of food on early drug exposure from extended-release stimulants: results from the Concerta, Adderall XR Food Evaluation (CAFE) Study. Curr Med Res Opin (2002) 2.04
Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. J Clin Invest (1984) 2.03
Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men. The Chicago Heart Association Detection Project in Industry Study. Diabetes Care (1997) 2.01
Resting heart rate is a risk factor for cardiovascular and noncardiovascular mortality: the Chicago Heart Association Detection Project in Industry. Am J Epidemiol (1999) 2.00
Association of nonspecific minor ST-T abnormalities with cardiovascular mortality: the Chicago Western Electric Study. JAMA (1999) 2.00
Functional expression of Drosophila para sodium channels. Modulation by the membrane protein TipE and toxin pharmacology. J Gen Physiol (1997) 1.99
Pulse pressure compared with other blood pressure indexes in the prediction of 25-year cardiovascular and all-cause mortality rates: The Chicago Heart Association Detection Project in Industry Study. Hypertension (2001) 1.94
Dietary guidelines for healthy American adults. A statement for health professionals from the Nutrition Committee, American Heart Association. Circulation (1996) 1.91
Oat products and lipid lowering. A meta-analysis. JAMA (1992) 1.90
Temperature-sensitive mutants with lesions in the vaccinia virus F10 kinase undergo arrest at the earliest stage of virion morphogenesis. J Virol (1995) 1.85
The yeast gene MSH3 defines a new class of eukaryotic MutS homologues. Mol Gen Genet (1993) 1.82
Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol (1986) 1.80
Lipoprotein lipids in older people. Results from the Cardiovascular Health Study. The CHS Collaborative Research Group. Circulation (1992) 1.79
Prevalence and correlates of mitral valve prolapse in a population-based sample of American Indians: the Strong Heart Study. Am J Med (2001) 1.78
Dynamic in vivo oxymetry using overhauser enhanced MR imaging. J Magn Reson Imaging (2000) 1.77
Obesity in the Pima Indians: its magnitude and relationship with diabetes. Am J Clin Nutr (1991) 1.77
Home care expenses for the disabled elderly. Health Care Financ Rev (1985) 1.77
Cloning and expression of a second photoreceptor-specific membrane retina guanylyl cyclase (RetGC), RetGC-2. Proc Natl Acad Sci U S A (1995) 1.77
The uptake of SV40 DNA by nonpermissive cells in the presence of DEAE-dextran. Biochim Biophys Acta (1971) 1.76
Epidemiology of low cholesterol levels in older adults. The Cardiovascular Health Study. Circulation (1993) 1.75
Association of hostility with coronary artery calcification in young adults: the CARDIA study. Coronary Artery Risk Development in Young Adults. JAMA (2000) 1.74
Analytical and biologic variability in measures of hemostasis, fibrinolysis, and inflammation: assessment and implications for epidemiology. Am J Epidemiol (1999) 1.73
Hypertension-related morbidity and mortality in the southeastern United States. Am J Med Sci (1997) 1.71
Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study. Am J Cardiol (2000) 1.71
A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia (1995) 1.70
An overview of long-term care. Health Care Financ Rev (1985) 1.69
Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS) Hypertension (1997) 1.69
Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. J Cancer Res Clin Oncol (2002) 1.69
Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med (1991) 1.68